Polymorphism, GeneticCardiovascular AgentsPolymorphism, Single NucleotideOxyfedrineGenetic Predisposition to DiseaseGenotypeGene FrequencyDisease SusceptibilityAllelesCase-Control StudiesHaplotypesPharmacoepidemiologyCardiovascular DiseasesAsian Continental Ancestry GroupRisk FactorsGenetic VariationCytochrome P-450 Enzyme SystemGenetic Association StudiesPolymerase Chain ReactionAryl Hydrocarbon HydroxylasesPharmaceutical PreparationsLinkage DisequilibriumGlutathione TransferaseDrug PrescriptionsPharmacogeneticsPhenotypeDrug UtilizationAdrenergic beta-AntagonistsDrug InteractionsCytochrome P-450 CYP2E1Metabolic Detoxication, DrugGenetic MarkersCytochrome P-450 CYP2D6Cytochrome P-450 CYP3ACalcium Channel BlockersChinaCohort StudiesArylamine N-AcetyltransferaseGenome-Wide Association StudyMolecular Sequence DataHypolipidemic AgentsPolymorphism, Restriction Fragment LengthBase SequenceHomozygoteGlutathione S-Transferase piHexobarbitalMethylenetetrahydrofolate Reductase (NADPH2)Cytochrome P-450 CYP1A1Sequence Analysis, DNAEuropean Continental Ancestry GroupBiotransformationGenetic LinkageChromosome MappingPharmacokineticsMutationAntihypertensive AgentsOdds RatioGlucuronosyltransferaseAngiotensin-Converting Enzyme InhibitorsPolymorphism, Single-Stranded ConformationalMicrosomes, LiverHeterozygoteHydroxymethylglutaryl-CoA Reductase InhibitorsCatechol O-MethyltransferaseAntipyrineLiverMixed Function OxygenasesJapanXenobioticsDNA PrimersMetabolic Detoxication, Phase IPromoter Regions, GeneticModels, GeneticMicrosatellite RepeatsSpecies SpecificityCytochrome P-450 CYP1A2Genetics, PopulationOxidoreductases, N-DemethylatingKoreaGenome, HumanMephenytoinEpistasis, GeneticExonsLipid MetabolismMetabolic Detoxication, Phase IIXeroderma Pigmentosum Group D ProteinGenetic LociRiskSmokingDNAAmino Acid SubstitutionPeptidyl-Dipeptidase ADNA Mutational AnalysisP-GlycoproteinGenetic TestingAmino Acid SequencePedigreeIsoenzymesAmplified Fragment Length Polymorphism AnalysisEnergy Metabolism